Liver Transplant Platelet Transfusion Outcomes with TEG Guidance

A retrospective cohort study analyzes 231 liver transplant patients from 2019 to 2023. It compares platelet usage and patient outcomes between groups receiving transfusions guided by Thromboelastography (TEG) MA values versus conventional platelet counts. The study reports transfusion percentages and quality-of-life scores from SF-36 surveys.

Use Cases

• Compare platelet transfusion percentages on postoperative days 1 and 3 between TEG and conventional platelet count groups.
• Analyze the relationship between TEG MA values and patient outcomes like quality-of-life scores from the SF-36 survey.
• Model the impact of TEG-guided transfusion strategies on platelet usage rates in a cohort of 231 liver transplant patients.
• Investigate potential confounders controlled via propensity score matching across the two patient groups.

Strengths

• Data covers 231 patients from a defined 5-year period (January 2019 to December 2023).
• Study design employs propensity score matching to control for confounders, strengthening causal inference.
• Outcomes include specific transfusion percentages and statistically significant quality-of-life metrics from the SF-36 survey.

Limitations

• The dataset is small in scale, derived from a single study's 231-patient cohort.
• Data is presented in a summary document format (DOCX), not as a structured, analyzable table.
• The retrospective design may have inherent biases not fully addressed by matching.

Provenance

Source

figshare, authored by Pingping Qi.

Collection Method

Retrospective cohort study of medical records from liver transplant patients.

Time Range

January 2019 to December 2023.

Freshness

Last updated in March 2026.